Diabetic retinopathy screening for children with type 1 diabetes should start later

Key points
- A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled.
- Ophthalmology, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically-applicable research.
- It is well established that early detection and timely treatment of diabetic retinopathy reduces vision loss in adults, and some physician organizations recommend screening children for diabetic retinopathy annually starting at an early age - after age 9, or from 3 to 5 years after diagnosis.
- Researchers based at The Children's Hospital of Philadelphia and the Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania began to question current diabetic retinopathy screening guidelines for children.
A new study has found that the occurrence of advanced forms of a diabetic eye disease remains low among children living with diabetes, regardless of how long they have had the disease or their ability to keep blood sugar levels controlled. Researchers are therefore recommending that most children with type 1 diabetes delay annual diabetic retinopathy screenings until age 15, or 5 years after their diabetes diagnosis, whichever occurs later. Their findings were published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.
It is well established that early detection and timely treatment of diabetic retinopathy reduces vision loss in adults, and some physician organizations recommend screening children for diabetic retinopathy annually starting at an early age - after age 9, or from 3 to 5 years after diagnosis. However, the value of screening children has not been clearly documented and the prevalence of severe diabetic retinopathy among the young has been unclear.
Researchers based at The Children's Hospital of Philadelphia and the Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania began to question current diabetic retinopathy screening guidelines for children. They were concerned that these annual exams may create an excessive financial and logistical burden for families and the health care system.
The researchers conducted a retrospective study of 370 children under age 18 with type 1 and type 2 diabetes. Some of the study participants had blood sugar levels three times that of a person without diabetes. All had received at least one diabetic eye disease screening exam between 2009 and 2013, but none were found to have diabetic retinopathy.
The researchers then examined the data that led to the current screening guidelines. They discovered that previous studies reported a diabetic retinopathy prevalence rate between 0 and 28 percent among children studied, but the majority of the cases were very mild and thus would not qualify for treatment. They also found that the youngest person reported to have severe diabetic retinopathy was between 15 and 19 years old, and 5 to 6 years was the shortest reported duration of having diabetes before developing severe diabetic retinopathy.
In light of the available evidence, the researchers recommend that screenings for children with type 1 diabetes could begin at a later age than previously recommended.
"Many of our young patients with diabetes diligently come in every year for screenings that consistently show no sign of the disease," said Gil Binenbaum, M.D., M.S.C.E., co-author of the study and attending surgeon in the ophthalmology division at The Children's Hospital of Philadelphia. "Of course, that's good news for them, and it is very important to have annual eye exams once the risk of vision loss develops. But, is it worth the burden on the family and the healthcare system if evidence shows that diabetic retinopathy doesn't reach a treatable stage until years later?"
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsBetter vision ahead for many diabetic retinopathy patients
A nationwide, government-sponsored study finds that people with a common form of diabetic retinopathy can benefit from a medication first developed to combat another potentially blinding disease, age-related macular…
28 April 2010
NewsStudy shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy
According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopathy, damage to the retina caused by leaky…
3 December 2009
NewsElevated arginase levels contribute to vascular eye disease such as diabetic retinopathy
Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as…






